The Ibex advances driven by progress in vaccinations

MADRID, Dec 14 (Reuters) – The Ibex-35 opened the week in positive terrain encouraged by the start of vaccinations in Europe and the United States, while the possibility of a Brexit deal was kept alive.

Hopes that vaccinations will avoid severe lockdowns in 2021 fueled risk appetite in global squares, after the US launched a historic campaign to inoculate more than 100 million people by the end of March, a critical milestone. in the United States’ efforts to control the virus.

On another important front, investors held out some hope that London and Brussels will come to fruition in their negotiations, after talks between the UK and the EU ended with a further extension on Sunday to try to reach a trade deal.

In this context, the selective Spanish stock exchange Ibex-35 closed with a rise of 77.70 points on Monday, 0.96%, to 8,140.80 points, while the index of large European stocks FTSE Eurofirst 300 rose 0, Four. Five%.

The banking sector boosted the index with Sabadell leading the day’s earnings with an advance of 3.90%. Santander rose 1.86%, BBVA registered 1.44%, Caixabank increased 1.46%, Bankia rose 1.03%, Sabadell gained 3.90%, and Bankinter revalued 3.71% .

Among the large non-financial securities, Telefónica fell 0.62%, Iberdrola revalued 0.31%, Cellnex fell 0.23% and the oil company Repsol lost 1.82%.

The textile giant Inditex advanced 3.98%, on the eve of the publication of its corporate results, scheduled for Wednesday before the opening of the markets.

The red lantern went to the Meliá hotel group, which fell by 1.55%.

(Information from Michael Susin; edited by Tomás Cobos)

–